These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19385009)

  • 1. Extended abstracts of the Annual Symposium of the Working Group for Pharmacology in Oncology and Hematology (APOH) of the Central European Society for Anticancer Drug Research (CESAR). June 12-14, 2008. Göttingen, Germany.
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-64. PubMed ID: 19385009
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended abstracts of the annual meeting of the Working Group for Pharmacology in Oncology and Hematology (APOH) of the Central European Society for Anticancer Drug Research (CESAR), Vienna, Austria, 2005.
    Int J Clin Pharmacol Ther; 2005 Dec; 43(12):566-608. PubMed ID: 16625725
    [No Abstract]   [Full Text] [Related]  

  • 3. The 8th annual meeting of CESAR in St. Gallen--novel therapeutic concepts in hemato-oncology.
    Morant R; Sehrt D; Jaehde U
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):58-9. PubMed ID: 21176728
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings of the 16th Meeting of the Working Group for Pharmacology in Oncology and Hematology. Munster, Germany, June 21-22, 2002.
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):560-88. PubMed ID: 12725233
    [No Abstract]   [Full Text] [Related]  

  • 5. American Society of Hematology--50th Annual Meeting and Exposition--Part 1.
    Scattereggia J; Millar E
    IDrugs; 2009 Feb; 12(2):63-5. PubMed ID: 19216123
    [No Abstract]   [Full Text] [Related]  

  • 6. The American Society of Hematology--46th Annual Meeting and Exposition. Drug highlights II.
    Evans L
    IDrugs; 2005 Jan; 8(1):10-3. PubMed ID: 15650933
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies in hematologic malignancies: clinical status. Highlights from the American Society of Hematology 42nd annual meeting. December 1-5, 2000, San Francisco, California, USA. Abstracts.
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 4):7-48. PubMed ID: 11357830
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Hematology--47th annual meeting and exposition.
    Murch L
    IDrugs; 2006 Feb; 9(2):84-6. PubMed ID: 16523392
    [No Abstract]   [Full Text] [Related]  

  • 9. Standard Operating Procedures for clinical trials of the CESAR Central European Society for Anticancer Drug Research--EWIV. Preface.
    Gastl G; Dittrich C
    Onkologie; 2003 Oct; 26 Suppl 6():IX. PubMed ID: 23570176
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trials and studies of the German Society for Paediatric Oncology and Haematology (GPOH) and the European Directive for the Implementation of Good Clinical Practice in the Conduct of Clinical Trials].
    Graf N; Göbel U
    Klin Padiatr; 2004; 216(3):129-31. PubMed ID: 15175956
    [No Abstract]   [Full Text] [Related]  

  • 11. The annual meeting of the American Society of Clinical Oncology. June 4-8, 2010; Chicago, IL.
    CIG Media Group
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):323-30. PubMed ID: 21030344
    [No Abstract]   [Full Text] [Related]  

  • 12. Marching against blood diseases: a report from the 51st Annual Meeting of the American Society of Hematology (December 5-8, 2009 - New Orleans, Lousiana, USA).
    Rabasseda X
    Drugs Today (Barc); 2010 Mar; 46(3):195-230. PubMed ID: 20467593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A report from the 46th Annual Meeting of the American Society of Clinical Oncology (June 4-8, 2010 - Chicago, Illinois, USA).
    Rabasseda X; Gómez-Zaera M
    Drugs Today (Barc); 2010 Sep; 46(9):699-731. PubMed ID: 20967301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Hematology--51st annual meeting & exposition. Part 1.
    Shumoogam J; Beecher N
    IDrugs; 2010 Feb; 13(2):57-9. PubMed ID: 20127549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American Society of Hematology--48th Annual Meeting and Exposition. Therapeutic approaches for hematological cancers. 9-12 December 2006 Orlando, FL, USA.
    Tear S
    IDrugs; 2007 Feb; 10(2):84-6. PubMed ID: 17285454
    [No Abstract]   [Full Text] [Related]  

  • 16. The 50th Annual Meeting of the American Society of Hematology.
    Cunningham S; Muneer S
    Clin Lymphoma Myeloma; 2009 Jun; 9(3):197-205. PubMed ID: 19525188
    [No Abstract]   [Full Text] [Related]  

  • 17. American Society of Hematology--48th Annual Meeting and Exposition. Updates on hematological therapies. 9-12 December 2006 Orlando, FL, USA.
    Walker K
    IDrugs; 2007 Feb; 10(2):78-80. PubMed ID: 17285452
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial. Approaches to personalized medicine in oncology--the 9th Annual Meeting of CESAR in Greifswald.
    Ritter C; Sehrt D; Jaehde U
    Int J Clin Pharmacol Ther; 2012 Jan; 50(1):53-4. PubMed ID: 22192647
    [No Abstract]   [Full Text] [Related]  

  • 19. Tubing determination in an hematology oncology clinic.
    Hsin J; Mitchell J; Thompson J; Kaneshiro C; Troncoso A
    J Oncol Pharm Pract; 2021 Jul; 27(5):1186-1188. PubMed ID: 33951974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 10 Years CESAR Anticancer Drug Research - The 7th CESAR Annual Meeting 2009. Preface.
    Edler L; Sehrt D; Scheulen ME
    Int J Clin Pharmacol Ther; 2010 Jul; 48(7):435-9. PubMed ID: 20557836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.